Re: Separation AgreementSeparation Agreement • November 5th, 2019 • XOMA Corp • Pharmaceutical preparations
This letter sets forth the substance of our agreement (“Agreement”) regarding the resignation of your employment with XOMA Corporation (the “Company”) and associated release of claims related to the Company and affiliated entities and persons as specified in the definition of “Releasees” in Section 8 of this Agreement (collectively, the “Releasees”). This Agreement will become effective upon the “Effective Date” defined in Section 9 of this Agreement and, except to the extent specified herein, shall then supersede all prior agreements, engagements, employments, arrangements, and relationships, whether written or oral, between you and the Releasees. This Agreement is the product of our discussions and negotiations over the past several weeks.
ROYALTY PURCHASE AGREEMENT dated as of September 26, 2019 between PALO BIOFARMA, S.L., as Seller, and XOMA (US) LLC, as PurchaserRoyalty Purchase Agreement • November 5th, 2019 • XOMA Corp • Pharmaceutical preparations • California
